Closing Out 2018 With A Review Of Some Of Our Successes In HIV Medicine

As we end 2018, I like to take a look back and review some of the good things that have happened this year. I will primarily focus on new treatments. But first a little history. In 2007, we had a banner year with three new drugs approved. These were not just any drugs but they were very important for a couple of reasons. First of all, Maraviroc was an important addition because it blocked the ability of HIV to infect blood cells in a unique way.